BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20240329T150604Z
UID:a49c8242-04df-49e3-809d-a70f4ee85afe
DTSTART:20210804T080000
DTEND:20210805T080000
CLASS:PRIVATE
DESCRIPTION:
\nImmunogenicity compromises both the
efficacy and safety of gene therapies and thus represents one of the most
prominent challenges that must be overcome in the field. Uniting translat
ional\, clinical\, regulatory and manufacturing gene therapy functions\, t
he inaugural Gene Therapy Immunogenicity Summit is the industry'\;s def
initive meeting enabling you to better measure\, modulate and predict immu
ne response and drive transformative treatments through the clinic to pati
ents more quickly and efficiently.
\n
\nKey topics of discussion
include:
\nEvaluating the suitability and success of current immunos
uppression agents in the context of gene therapy
\nEmploying risk ass
essment tools to develop clinical bioanalytical and immunogenicity monitor
ing strategies
\nDissecting the immunogenicity of gene therapy vector
s to better understand immunology safety concerns
\nBetter understand
ing the innate immune response and its implications for gene therapy trans
duction
\nEvaluating the resolution and throughput of technologies to
define empty vs full capsid presence
\nImplementing the use of precl
inical risk assessment tools to drive clinical immunogenicity strategies f
or gene therapy modalities
\nWhat the implications are for the safety
and efficacy of gene therapies if re-dosing is to occur
\n
\nURLs:
\nTickets: https://go.evvnt.com/614539-2?pid=1052
\nBrochure: https://go.evvnt.com/614539
-3?pid=1052
SUMMARY:Gene Therapy Immunogenicity - Virtual Summit
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-PT1H
SUMMARY:Gene Therapy Immunogenicity - Virtual Summit
END:VALARM
END:VEVENT
END:VCALENDAR